Retroviral integration profiles: their determinants and implications for gene therapy

키워드

참고문헌 (49)

1. Coffin, J. M., "Retroviruses" (1997), Cold Spring Harbor Lab. Press
2. Knipe, D. M., "Fields Virology" (2006), Lippincott Williams & Wilkins
3. Doi, K., "Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states", Blood, 106, pp.1048~1053 (2005)
4. Guss, D. A., "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 2", J. Emerg. Med., 12, pp.491~497 (1994)
5. Guss, D. A., "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 1", J. Emerg. Med., 12, pp.375~384 (1994)
6. Fan, H., "A new human retrovirus associated with prostate cancer", Proc. Natl. Acad. Sci. U.S.A., 104, pp.1449~1450 (2007)
7. Shimotohno, K., "Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector", Nature, 299, pp.265~268 (1982)
8. Watanabe, S., "Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors", Mol. Cell. Biol., 3, pp.2241~2249 (1983)
9. 임광일, "Molecular engineering of viral gene delivery vehicles", ANNUAL REVIEW OF BIOMEDICAL ENGINEERING Book Series: ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, 10, pp.169~194 (2008), ANNUAL REVIEWS
10. Schambach, A., "Clinical application of lentiviral vectors - concepts and practice", Curr. Gene Ther., 8, pp.474~482 (2008)
11. Hacein-Bey-Abina, S., "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1", Science, 302, pp.415~419 (2003)
12. Cavazzana-Calvo, M., "Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia", Nature, 467, pp.318~322 (2010)
13. Aiuti, A., "Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning", Science, 296, pp.2410~2413 (2002)
14. Ott, M. G., "Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1", Nat. Med., 12, pp.401~409 (2006)
15. Takahashi, K., "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, 126, pp.663~676 (2006)
16. Wu, X., "Transcription start regions in the human genome are favored targets for MLV integration", Science, 300, pp.1749~1751 (2003)
17. Lim, K. I., "Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties", Proc. Natl. Acad. Sci. U.S.A., 107, pp.12475~12480 (2010)
18. Tsukahara, T., "Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line", Biochem. Biophys. Res. Commun., 345, pp.1099~1107 (2006)
19. Hematti, P., "Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells", PLoS Biol., 2, pp.e423~ (2004)
20. Maruggi, G., "Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design", Mol. Ther., 17, pp.851~856 (2009)
21. Beard, B. C., "Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells", Mol. Ther., 15, pp.1356~1365 (2007)
22. Felice, B., "Transcription factor binding sites are genetic determinants of retroviral integration in the human genome", PLoS One., 4, pp.e4571~ (2009)
23. Moalic, Y., "Genome areas with high gene density and CpG island neighborhood strongly attract porcine endogenous retrovirus for integration and favor the formation of hot spots", J. Virol., 83, pp.1920~1929 (2009)
24. Kim, S., "Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer", J. Virol., 82, pp.9964~9977 (2008)
25. Schroder, A. R., "HIV-1 integration in the human genome favors active genes and local hotspots", Cell, 110, pp.521~529 (2002)
26. Mitchell, R. S., "Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences", PLoS Biol., 2, pp.E234~ (2004)
27. Ciuffi, A., "Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts", Mol. Ther., 13, pp.366~373 (2006)
28. Crise, B., "Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1", J. Virol., 79, pp.12199~12204 (2005)
29. Monse, H., "Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors", J. Virol., 80, pp.8145~8150 (2006)
30. Montini, E., "Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration", Nat. Biotechnol., 24, pp.687~696 (2006)
31. Nowrouzi, A., "Genome-wide mapping of foamy virus vector integrations into a human cell line", J. Gen. Virol., 87, pp.1339~1347 (2006)
32. Meekings, K. N., "HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM", TSP, 2008, pp.4, e1000027~
33. Gillet, N. A., "The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones", Blood, 117, pp.3113~3122 (2011)
34. Lewinski, M. K., "Retroviral DNA integration: viral and cellular determinants of target-site selection", PLoS Pathog., 2, pp.e60~ (2006)
35. Appa, R. S., "Role of the nonspecific DNA-binding region and alpha helices within the core domain of retroviral integrase in selecting target DNA sites for integration", J. Biol. Chem., 276, pp.45848~45855 (2001)
36. Maertens, G. N., "The mechanism of retroviral integration from X-ray structures of its key intermediates", Nature, 468, pp.326~329 (2010)
37. Studamire, B., "Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors", Retrovirology, 5, pp.48~ (2008)
38. Ciuffi, A., "A role for LEDGF", p75 in targeting HIV DNA integration, 2005, pp.11, 1287~1289
39. Shun, M. C., "LEDGF", p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration, 2007, pp.21, 1767~1778
40. Ocwieja, K. E., "HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2", PLoS Pathog., 7, pp.e1001313~ (2011)
41. Konig, R., "Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication", Cell, 135, pp.49~60 (2008)
42. Wang, G. P., "HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications", Genome Res., 17, pp.1186~1194 (2007)
43. Tan, W., "Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells", J. Virol., 80, pp.1939~1948 (2006)
44. Katz, R. A., "Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles", Virology, 217, pp.178~190 (1996)
45. Goulaouic, H., "Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein", J. Virol., 70, pp.37~46 (1996)
46. Bushman, F. D., "Tethering human immunodeficiency virus1 integrase to a DNA site directs integration to nearbysequences", Proc. Natl. Acad. Sci. U.S.A., 91, pp.9233~9237 (1994)
47. Philippe, S., "Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo", Proc. Natl. Acad. Sci. U.S.A., 103, pp.17684~17689 (2006)
48. Yanez-Munoz, R. J., "Effective gene therapy with nonintegrating lentiviral vectors", Nat. Med., 12, pp.348~353 (2006)
49. Cattoglio, C., "High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors", Blood, 116, pp.5507~5517 (2010)

관련 논문AI추천